These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Characteristics of incident geographic atrophy in the complications of age-related macular degeneration prevention trial. Brader HS; Ying GS; Martin ER; Maguire MG; Ophthalmology; 2013 Sep; 120(9):1871-9. PubMed ID: 23622873 [TBL] [Abstract][Full Text] [Related]
23. OCT risk factors for 2-year foveal involvement in non-treated eyes with extrafoveal geographic atrophy and AMD. Borrelli E; Barresi C; Berni A; Viggiano P; Reibaldi M; Introini U; Bandello F Graefes Arch Clin Exp Ophthalmol; 2024 Jul; 262(7):2101-2109. PubMed ID: 38326629 [TBL] [Abstract][Full Text] [Related]
24. Experience With a Subretinal Cell-based Therapy in Patients With Geographic Atrophy Secondary to Age-related Macular Degeneration. Ho AC; Chang TS; Samuel M; Williamson P; Willenbucher RF; Malone T Am J Ophthalmol; 2017 Jul; 179():67-80. PubMed ID: 28435054 [TBL] [Abstract][Full Text] [Related]
25. The Natural History of the Progression of Atrophy Secondary to Stargardt Disease (ProgStar) Studies: Design and Baseline Characteristics: ProgStar Report No. 1. Strauss RW; Ho A; Muñoz B; Cideciyan AV; Sahel JA; Sunness JS; Birch DG; Bernstein PS; Michaelides M; Traboulsi EI; Zrenner E; Sadda S; Ervin AM; West S; Scholl HP; Ophthalmology; 2016 Apr; 123(4):817-28. PubMed ID: 26786511 [TBL] [Abstract][Full Text] [Related]
26. Complement C3 Inhibitor Pegcetacoplan for Geographic Atrophy Secondary to Age-Related Macular Degeneration: A Randomized Phase 2 Trial. Liao DS; Grossi FV; El Mehdi D; Gerber MR; Brown DM; Heier JS; Wykoff CC; Singerman LJ; Abraham P; Grassmann F; Nuernberg P; Weber BHF; Deschatelets P; Kim RY; Chung CY; Ribeiro RM; Hamdani M; Rosenfeld PJ; Boyer DS; Slakter JS; Francois CG Ophthalmology; 2020 Feb; 127(2):186-195. PubMed ID: 31474439 [TBL] [Abstract][Full Text] [Related]
27. Progression of Geographic Atrophy in Age-related Macular Degeneration: AREDS2 Report Number 16. Keenan TD; Agrón E; Domalpally A; Clemons TE; van Asten F; Wong WT; Danis RG; Sadda S; Rosenfeld PJ; Klein ML; Ratnapriya R; Swaroop A; Ferris FL; Chew EY; Ophthalmology; 2018 Dec; 125(12):1913-1928. PubMed ID: 30060980 [TBL] [Abstract][Full Text] [Related]
32. Low luminance visual dysfunction as a predictor of subsequent visual acuity loss from geographic atrophy in age-related macular degeneration. Sunness JS; Rubin GS; Broman A; Applegate CA; Bressler NM; Hawkins BS Ophthalmology; 2008 Sep; 115(9):1480-8, 1488.e1-2. PubMed ID: 18486216 [TBL] [Abstract][Full Text] [Related]
33. Local Progression Kinetics of Geographic Atrophy in Age-Related Macular Degeneration Are Associated With Atrophy Border Morphology. Lindner M; Kosanetzky S; Pfau M; Nadal J; Gördt LA; Schmitz-Valckenberg S; Schmid M; Holz FG; Fleckenstein M; Invest Ophthalmol Vis Sci; 2018 Mar; 59(4):AMD12-AMD18. PubMed ID: 29558533 [TBL] [Abstract][Full Text] [Related]